<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37638015</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Myeloid-associated differentiation marker is associated with type 2 asthma and is upregulated by human rhinovirus infection.</ArticleTitle><Pagination><StartPage>1237683</StartPage><MedlinePgn>1237683</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1237683</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1237683</ELocationID><Abstract><AbstractText Label="BACKGROUND">Human rhinoviruses are known to predispose infants to asthma development during childhood and are often associated with exacerbations in asthma patients. MYADM epithelial expression has been shown to associate with asthma severity. The goal of this study was to determine if MYADM expression patterns were altered in asthma and/or rhinovirus infection and if increased MYADM expression is associated with increased asthma-associated factors.</AbstractText><AbstractText Label="METHODS">Utilizing H1HeLa cells and differentiated primary human airway epithelial cells (AECs), we measured the expression of MYADM and inflammatory genes by qRT-PCR in the presence or absence of RV-1B infection or poly I:C treatment and with siRNA knockdown of MYADM. Expression of MYADM in the asthmatic lung was determined in the ovalbumin (ova)-challenged murine model.</AbstractText><AbstractText Label="RESULTS">MYADM expression was upregulated in the lungs from ova-treated mice and in particular on the subsurface vesicle membrane in airway epithelial cells. Upon infection with RV-1B, human AECs grown at an air-liquid interface had increased the MYADM expression predominantly detected in ciliated cells. We found that the presence of MYADM was required for expression of several inflammatory genes both in a resting state and after RV-1B or poly I:C treatments.</AbstractText><AbstractText Label="CONCLUSIONS">Our studies show that in a mouse model of asthma and during RV-1B infection of primary human AECs, increased MYADM expression is observed. In the mouse model of asthma, MYADM expression was predominantly on the luminal side of airway epithelial cells. Additionally, MYADM expression was strongly associated with increases in inflammatory genes, which may contribute to more severe asthma and RV-linked asthma exacerbations.</AbstractText><CopyrightInformation>Copyright © 2023 Tanyaratsrisakul, Dy, Polverino, Numata and Ledford.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tanyaratsrisakul</LastName><ForeName>Sasipa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Asthma and Airway Disease Research Center, University of Arizona, Tucson, AZ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dy</LastName><ForeName>Alane Blythe C</ForeName><Initials>ABC</Initials><AffiliationInfo><Affiliation>Asthma and Airway Disease Research Center, University of Arizona, Tucson, AZ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polverino</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medicine, Baylor College of Medicine, Houston, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Numata</LastName><ForeName>Mari</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, National Jewish Health, Denver, CO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ledford</LastName><ForeName>Julie G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Asthma and Airway Disease Research Center, University of Arizona, Tucson, AZ, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 ES006694</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI125357</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 HL132821</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL142769</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9006-59-1</RegistryNumber><NameOfSubstance UI="D010047">Ovalbumin</NameOfSubstance></Chemical><Chemical><RegistryNumber>O84C90HH2L</RegistryNumber><NameOfSubstance UI="D011070">Poly I-C</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000943">Antigens, Differentiation</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010047" MajorTopicYN="N">Ovalbumin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011070" MajorTopicYN="N">Poly I-C</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000943" MajorTopicYN="N">Antigens, Differentiation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MYADM</Keyword><Keyword MajorTopicYN="N">airway epithelial cells</Keyword><Keyword MajorTopicYN="N">asthma</Keyword><Keyword MajorTopicYN="N">human rhinovirus</Keyword><Keyword MajorTopicYN="N">lung inflammation</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>29</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>28</Day><Hour>4</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37638015</ArticleId><ArticleId IdType="pmc">PMC10450947</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1237683</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pettersson M, Dannaeus K, Nilsson K, Jonsson JI. Isolation of MYADM, a novel hematopoietic-associated marker gene expressed in multipotent progenitor cells and up-regulated during myeloid differentiation. J Leukoc Biol (2000) 67(3):423–31. doi: 10.1002/jlb.67.3.423</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jlb.67.3.423</ArticleId><ArticleId IdType="pubmed">10733104</ArticleId></ArticleIdList></Reference><Reference><Citation>Dannaeus K, Bessonova M, Jönsson JI. Characterization of the mouse myeloid-associated differentiation marker (myadm) gene: Promoter analysis and protein localization. Mol Biol Rep (2005) 32(3):149–57. doi: 10.1007/s11033-005-0753-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-005-0753-x</ArticleId><ArticleId IdType="pubmed">16172915</ArticleId></ArticleIdList></Reference><Reference><Citation>De Wit NJW, Rijntjes J, Diepstra JHS, van Kuppevelt TH, Weidle UH, Ruiter DJ, et al. . Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays. Br J Cance. (2005) 92(12):2249–61. doi: 10.1038/sj.bjc.6602612</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjc.6602612</ArticleId><ArticleId IdType="pmc">PMC2361822</ArticleId><ArticleId IdType="pubmed">15900300</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Li N, Wang X, Shen J, Hong X, Yu H, et al. . Membrane protein hMYADM preferentially expressed in myeloid cells is up-regulated during differentiation of stem cells and myeloid leukemia cells. Life Sci (2007) 80(5):420–9. doi: 10.1016/j.lfs.2006.09.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2006.09.043</ArticleId><ArticleId IdType="pubmed">17097684</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, Chen Y, Gu X. Wang C. A comprehensive bioinformatic analysis for identification of myeloid-associated differentiation marker as a potential negative prognostic biomarker in non-small-cell lung cancer. Pathol Oncol Res (2022) 28:1610504. doi: 10.3389/pore.2022.1610504</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/pore.2022.1610504</ArticleId><ArticleId IdType="pmc">PMC9437211</ArticleId><ArticleId IdType="pubmed">36061144</ArticleId></ArticleIdList></Reference><Reference><Citation>Ute Bracker T, Sommer A, Fichtner I, Faus H, Haendler B, Hess-Stumpp H. Efficacy of MS-275, a selective inhibitor of class I histone deacetylases, in human colon cancer models. Int J Oncol (2009) 35(4):909–20. doi: 10.3892/ijo_00000406</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo_00000406</ArticleId><ArticleId IdType="pubmed">19724929</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeller T, Schurmann C, Schramm K, Müller C, Kwon S, Wild PS, et al. . Transcriptome-wide analysis identifies novel associations with blood pressure. Hypertension (2017) 70(4):743–50. doi: 10.1161/HYPERTENSIONAHA.117.09458</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.117.09458</ArticleId><ArticleId IdType="pmc">PMC5997260</ArticleId><ArticleId IdType="pubmed">28784648</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Lin P, Chen Y, Yu H, Ren S, Wang J, et al. . miR-182-3p/Myadm contribute to pulmonary artery hypertension vascular remodeling via a KLF4/p21-dependent mechanism. Theranostics (2020) 10(12):5581–99. doi: 10.7150/thno.44687</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.44687</ArticleId><ArticleId IdType="pmc">PMC7196306</ArticleId><ArticleId IdType="pubmed">32373233</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y, Wang J, Chen Y, Lv T, Wang X, Liu C, et al. . The miR-182/Myadm axis regulates hypoxia-induced pulmonary hypertension by balancing the BMP- and TGF-β-signalling pathways in an SMC/EC-crosstalk-associated manner. Basic Res Cardiol (2021) 116(1):52–73. doi: 10.1007/s00395-021-00892-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-021-00892-6</ArticleId><ArticleId IdType="pubmed">34546460</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Zhang Z, Liang C, Lv T, Yu H, Ren S, et al. . Targeting myadm to intervene pulmonary hypertension on rats before pregnancy alleviates the effect on their offspring’s cardiac-cerebral systems. Front Pharmacol (2022) 12:791370. doi: 10.3389/fphar.2021.791370</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.791370</ArticleId><ArticleId IdType="pmc">PMC8804385</ArticleId><ArticleId IdType="pubmed">35115938</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranda JF, Reglero-Real N, Kremer L, Marcos-Ramiro B, Ruiz-Sáenz A, Calvo M, et al. . MYADM regulates Rac1 targeting to ordered membranes required for cell spreading and migration. Mol Biol Cell (2011) 22(8):1252–62. doi: 10.1091/mbc.E10-11-0910</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E10-11-0910</ArticleId><ArticleId IdType="pmc">PMC3078064</ArticleId><ArticleId IdType="pubmed">21325632</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranda JF, Reglero-Reala N, Marcos-Ramiro B, Ruiz-Sáenz A, Fernández-Martín L, Bernabé-Rubio M, et al. . MYADM controls endothelial barrier function through ERM-dependent regulation of ICAM-1 expression. Mol Biol Cell (2013) 24(4):483–94. doi: 10.1091/mbc.E11-11-0914</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E11-11-0914</ArticleId><ArticleId IdType="pmc">PMC3571871</ArticleId><ArticleId IdType="pubmed">23264465</ArticleId></ArticleIdList></Reference><Reference><Citation>Dy ABC, Langlais PR, Barker NK, Addison KJ, Tanyaratsrisakul S, Sasipa Boitano S, et al. . Myeloid-associated differentiation marker is a novel SP-A-associated transmembrane protein whose expression on airway epithelial cells correlates with asthma severity. Sci Rep (2021) 11(1). doi: 10.1038/s41598-021-02869-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-02869-w</ArticleId><ArticleId IdType="pmc">PMC8642528</ArticleId><ArticleId IdType="pubmed">34862427</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo JR, Peters SP, Busse WW. Asthma exacerbations: pathogenesis, prevention, and treatment. J Allergy Clin Immunology: In Pract (2017) 5(4):918–27. doi: 10.1016/j.jaip.2017.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2017.05.001</ArticleId><ArticleId IdType="pmc">PMC5950727</ArticleId><ArticleId IdType="pubmed">28689842</ArticleId></ArticleIdList></Reference><Reference><Citation>Çalışkan M, Bochkov YA, Kreiner-Møller E, Bønnelykke K, Stein MM, Du G, et al. . Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. New Engl J Med (2013) 368(15):1398–407. doi: 10.1056/nejmoa1211592</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa1211592</ArticleId><ArticleId IdType="pmc">PMC3755952</ArticleId><ArticleId IdType="pubmed">23534543</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansbach JM, Geller RJ, Hasegawa K, Piedra PA, Avadhanula V, Gern JE, et al. . Detection of respiratory syncytial virus or rhinovirus weeks after hospitalization for bronchiolitis and the risk of recurrent wheezing. J Infect Dis (2021) 223(2):268–77. doi: 10.1093/infdis/jiaa348</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa348</ArticleId><ArticleId IdType="pmc">PMC7857353</ArticleId><ArticleId IdType="pubmed">32564083</ArticleId></ArticleIdList></Reference><Reference><Citation>Michi AN, Love ME, Proud D. Rhinovirus-induced modulation of epithelial phenotype: Role in asthma. Viruse (2020) 12 (11):1328. doi: 10.3390/v12111328</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12111328</ArticleId><ArticleId IdType="pmc">PMC7699223</ArticleId><ArticleId IdType="pubmed">33227953</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson DJ, Gern JE. Rhinovirus infections and their roles in asthma: etiology and exacerbations. J Allergy Clin Immunology: In Pract (2022) 10(3):673–81. doi: 10.1016/j.jaip.2022.01.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2022.01.006</ArticleId><ArticleId IdType="pmc">PMC10314805</ArticleId><ArticleId IdType="pubmed">35074599</ArticleId></ArticleIdList></Reference><Reference><Citation>Grünberg K, Timmers MC, De Klerk EPA, Dick EC, Sterk PJ. Experimental Rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma. Am J Respir Crit Care Med (1999) 160:1375–1380.</Citation><ArticleIdList><ArticleId IdType="pubmed">10508832</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy JL, Koziol-White CJ, Jeffus S, Rettiganti MR, Fisher P, Kurten M, et al. . Effects of rhinovirus 39 infection on airway hyperresponsiveness to carbachol in human airways precision cut lung slices. J Allergy Clin Immunol (2018) 141(5):1887–1890.e1. doi: 10.1016/j.jaci.2017.11.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2017.11.041</ArticleId><ArticleId IdType="pmc">PMC5938135</ArticleId><ArticleId IdType="pubmed">29317243</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh V, Scala J, Patel R, Corbi C, Lo D, Bochkov YA, et al. . Rhinovirus C15 induces airway hyperresponsiveness via calcium mobilization in airway smooth muscle. Am J Respir Cell Mol Biol (2020) 62(3):310–8. doi: 10.1165/rcmb.2019-0004OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2019-0004OC</ArticleId><ArticleId IdType="pmc">PMC7055698</ArticleId><ArticleId IdType="pubmed">31533004</ArticleId></ArticleIdList></Reference><Reference><Citation>Niespodziana K, Stenberg-Hammar K, Papadopoulos NG, Focke-Tejkl M, Errhalt P, Konradsen JR, et al. . Microarray technology may reveal the contribution of allergen exposure and rhinovirus infections as possible triggers for acute wheezing attacks in preschool children. Viruses (2021) 13(5):915. doi: 10.3390/v13050915</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13050915</ArticleId><ArticleId IdType="pmc">PMC8155838</ArticleId><ArticleId IdType="pubmed">34063445</ArticleId></ArticleIdList></Reference><Reference><Citation>Polverino F, Stern DA, Snyder EM, Wheatley-Guy C, Bhatt SP, Martinez FD, et al. . Lower respiratory illnesses in childhood are associated with the presence of air trapping in early adulthood. Respir Med (2023) 206. doi: 10.1016/j.rmed.2022.107062</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2022.107062</ArticleId><ArticleId IdType="pmc">PMC10389168</ArticleId><ArticleId IdType="pubmed">36508986</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Nagarkar DR, Bowman ER, Schneider D, Gosangi B, Lei J, et al. . Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J Immunol (2009) 183(11):6989–97. doi: 10.4049/jimmunol.0901386</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0901386</ArticleId><ArticleId IdType="pmc">PMC2920602</ArticleId><ArticleId IdType="pubmed">19890046</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Miller DJ, Bowman ER, Nagarkar DR, Schneider D, Zhao Y, et al. . MDA5 and TLR3 initiate pro-inflammatory signaling pathways leading to rhinovirus-induced airways inflammation and hyperresponsiveness. PloS Pathog (2011) 7(5). doi: 10.1371/journal.ppat.1002070</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002070</ArticleId><ArticleId IdType="pmc">PMC3102730</ArticleId><ArticleId IdType="pubmed">21637773</ArticleId></ArticleIdList></Reference><Reference><Citation>Numata M, Sajuthi S, Bochkov YA, Loeffler J, Everman J, Vladar EK, et al. . Anionic pulmonary surfactant lipid treatment inhibits rhinovirus A infection of the human airway epithelium. Viruses (2023) 15(3):747. doi: 10.3390/v15030747</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15030747</ArticleId><ArticleId IdType="pmc">PMC10055697</ArticleId><ArticleId IdType="pubmed">36992456</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee WM, Monroe SS, Rueckert RR. Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosome. (1993) 67 (4):2110–22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC240305</ArticleId><ArticleId IdType="pubmed">8383233</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallak LK, Spillmann D, Collins PL, Peeples ME. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J Virol (2000) 74(22):10508–13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC110925</ArticleId><ArticleId IdType="pubmed">11044095</ArticleId></ArticleIdList></Reference><Reference><Citation>Dy ABC, Arif MZ, Addison KJ, Que LG, Boitano S, Kraft M, et al. . Genetic variation in surfactant protein-A2 delays resolution of eosinophilia in asthma. J Immunol (2019) 203(5):1122–30. doi: 10.4049/jimmunol.1900546</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1900546</ArticleId><ArticleId IdType="pmc">PMC6702058</ArticleId><ArticleId IdType="pubmed">31350355</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>